Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 65301 - 65325 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	MIR181C	406957	upregulated	resveratrol results in increased expression of MIR181C mRNA	19p13.12	A23973
Resveratrol	Investigational	MIR183	406959	upregulated	resveratrol results in increased expression of MIR183 mRNA	7q32.2	A23975
Resveratrol	Investigational	MIR185	406961	downregulated	resveratrol results in decreased expression of MIR185 mRNA	22q11.21	A23975
Resveratrol	Investigational	MIR195	406971	downregulated	resveratrol results in decreased expression of MIR195 mRNA	17p13.1	A23975
Resveratrol	Investigational	MIR196A1	406972	downregulated	resveratrol results in decreased expression of MIR196A1 mRNA	17q21.32	A23974
Resveratrol	Investigational	MIR198	406975	downregulated	resveratrol results in decreased expression of MIR198 mRNA	3q13.33	A23975
Resveratrol	Investigational	MIR19A	406979	upregulated	resveratrol results in increased expression of MIR19A mRNA	13q31.3	A23973
Resveratrol	Investigational	MIR200C	406985	downregulated	resveratrol results in decreased expression of MIR200C mRNA	12p13.31	A23975
Resveratrol	Investigational	MIR200C	406985	upregulated	resveratrol results in increased expression of MIR200C mRNA	12p13.31	A23973 A23851
Resveratrol	Investigational	MIR202	574448	upregulated	resveratrol results in increased expression of MIR202 mRNA	10q26.3	A23973
Resveratrol	Investigational	MIR203A	406986	upregulated	resveratrol results in increased expression of MIR203A mRNA	14q32.33	A23973
Resveratrol	Investigational	MIR205	406988	downregulated	resveratrol results in decreased expression of MIR205 mRNA	1q32.2	A23974
Resveratrol	Investigational	MIR206	406989	upregulated	resveratrol results in increased expression of MIR206 mRNA	6p12.2	A23974
Resveratrol	Investigational	MIR20B	574032	upregulated	resveratrol results in increased expression of MIR20B mRNA	Xq26.2	A23973
Resveratrol	Investigational	MIR21	406991	downregulated	resveratrol results in decreased expression of MIR21 mRNA	17q23.1	A23974 A20395 A23978 A23979
Resveratrol	Investigational	MIR23A	407010	downregulated	resveratrol results in decreased expression of MIR23A mRNA	19p13.12	A23974
Resveratrol	Investigational	MIR23B	407011	downregulated	resveratrol results in decreased expression of MIR23B mRNA	9q22.32	A23974
Resveratrol	Investigational	MIR23B	407011	upregulated	resveratrol results in increased expression of MIR23B mRNA	9q22.32	A23975
Resveratrol	Investigational	MIR25	407014	downregulated	resveratrol results in decreased expression of MIR25 mRNA	7q22.1	A23974
Resveratrol	Investigational	MIR26A1	407015	downregulated	resveratrol results in decreased expression of MIR26A1 mRNA	3p22.2	A23974
Resveratrol	Investigational	MIR29A	407021	upregulated	resveratrol results in increased expression of MIR29A mRNA	7q32.3	A23973
Resveratrol	Investigational	MIR29C	407026	downregulated	resveratrol results in decreased expression of MIR29C mRNA	1q32.2	A23974
Resveratrol	Investigational	MIR29C	407026	upregulated	resveratrol results in increased expression of MIR29C mRNA	1q32.2	A23973
Resveratrol	Investigational	MIR301B	100126318	downregulated	resveratrol results in decreased expression of MIR301B mRNA	22q11.21	A23975
Resveratrol	Investigational	MIR302B	442894	upregulated	resveratrol results in increased expression of MIR302B mRNA	4q25	A23973

Displaying entries 65301 - 65325 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability